Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin W Teh

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
The Journal of Infectious Diseases|August 4, 2023
COVID-19 Vaccination in Patients With Cancer and Patients Receiving HSCT or CAR-T Therapy: Immune Response, Real-World Effectiveness, and Implications for the FutureVictoria G Hall, Benjamin W Teh
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 29, 2023
Vaccine schedule recommendations and updates for patients with hematologic malignancy post-hematopoietic cell transplant or CAR T-cell therapyGemma Reynolds, Victoria G Hall, Benjamin W Teh
Current Opinion in Infectious Diseases|November 6, 2019
Azole antifungals and new targeted therapies for hematological malignancyJulian Lindsay, Benjamin W Teh, Ken Micklethwaite, et al.
Current Opinion in Infectious Diseases|May 27, 2021
Choice and duration of antifungal prophylaxis and treatment in high-risk haematology patientsJulien Coussement, Julian Lindsay, Benjamin W Teh, et al.
Australian Health Review : a Publication of the Australian Hospital Association|September 19, 2019
National cost savings from an ambulatory program for low-risk febrile neutropenia patients in AustraliaMichelle Tew, Daniel Forster, Benjamin W Teh, et al.
Leukemia & Lymphoma|October 11, 2022
Immunoglobulin replacement in hematological malignancies: a focus on evidence, alternatives, dosing strategy, and cessation ruleBeatrice Sim, Jun Yen Ng, Benjamin W Teh, et al.
Current Opinion in Infectious Diseases|October 3, 2024
Chimeric antigen receptor-T-cell therapies going viral: latent and incidental viral infectionsEleftheria Kampouri, Gemma Reynolds, Benjamin W Teh, et al.
European Journal of Haematology|October 8, 2016
Epidemiology of bloodstream infections in patients with myeloma receiving current era therapyBenjamin W Teh, Simon J Harrison, Monica A Slavin, et al.
Expert Review of Anti-Infective Therapy|October 23, 2015
Prevention of viral infections in patients with multiple myeloma: the role of antiviral prophylaxis and immunizationBenjamin W Teh, Monica A Slavin, Simon J Harrison, et al.
Blood Reviews|March 7, 2021
Bispecific antibody therapy, its use and risks for infection: Bridging the knowledge gapAnthony P Longhitano, Monica A Slavin, Simon J Harrison, et al.
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
The Journal of Infectious Diseases|August 4, 2023
COVID-19 Vaccination in Patients With Cancer and Patients Receiving HSCT or CAR-T Therapy: Immune Response, Real-World Effectiveness, and Implications for the FutureVictoria G Hall, Benjamin W Teh
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 29, 2023
Vaccine schedule recommendations and updates for patients with hematologic malignancy post-hematopoietic cell transplant or CAR T-cell therapyGemma Reynolds, Victoria G Hall, Benjamin W Teh
Current Opinion in Infectious Diseases|November 6, 2019
Azole antifungals and new targeted therapies for hematological malignancyJulian Lindsay, Benjamin W Teh, Ken Micklethwaite, et al.
Current Opinion in Infectious Diseases|May 27, 2021
Choice and duration of antifungal prophylaxis and treatment in high-risk haematology patientsJulien Coussement, Julian Lindsay, Benjamin W Teh, et al.
Australian Health Review : a Publication of the Australian Hospital Association|September 19, 2019
National cost savings from an ambulatory program for low-risk febrile neutropenia patients in AustraliaMichelle Tew, Daniel Forster, Benjamin W Teh, et al.
Leukemia & Lymphoma|October 11, 2022
Immunoglobulin replacement in hematological malignancies: a focus on evidence, alternatives, dosing strategy, and cessation ruleBeatrice Sim, Jun Yen Ng, Benjamin W Teh, et al.
Current Opinion in Infectious Diseases|October 3, 2024
Chimeric antigen receptor-T-cell therapies going viral: latent and incidental viral infectionsEleftheria Kampouri, Gemma Reynolds, Benjamin W Teh, et al.
European Journal of Haematology|October 8, 2016
Epidemiology of bloodstream infections in patients with myeloma receiving current era therapyBenjamin W Teh, Simon J Harrison, Monica A Slavin, et al.
Expert Review of Anti-Infective Therapy|October 23, 2015
Prevention of viral infections in patients with multiple myeloma: the role of antiviral prophylaxis and immunizationBenjamin W Teh, Monica A Slavin, Simon J Harrison, et al.
Blood Reviews|March 7, 2021
Bispecific antibody therapy, its use and risks for infection: Bridging the knowledge gapAnthony P Longhitano, Monica A Slavin, Simon J Harrison, et al.
Pageof 7